This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Abituzumab

Merck KGaA

Drug Names(s): EMD 525797, DI17E6

Description: EMD 525797 is a monoclonal antibody specific for the human alpha-V integrin subunit. It inhibits human endothelial adhesion to vitronectin and has the potential of inducing apoptosis in alpha-V-beta-3 expressing tumor cells.


Abituzumab News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug